The effect of initial intravitreal tissue plasminogen activator and gas injection on vision improvement in patients with submacular haemorrhage associated with age-related macular degeneration.

Published on Jan 9, 2021in Eye2.455
· DOI :10.1038/S41433-020-01383-Z
Seung Ha Lee (Kosin University), Sang Joon Lee11
Estimated H-index: 11
(Kosin University)
+ 4 AuthorsKi Yup Nam10
Estimated H-index: 10
(CNU: Chungnam National University)
Sources
Abstract
PURPOSE To compare visual improvements between initial intravitreal t-PA with gas injection before anti-vascular endothelial growth factor (VEGF) and anti-VEGF injection monotherapy for submacular haemorrhage (SMH) associated with age-related macular degeneration (AMD). METHODS We retrospectively reviewed medical records of naive patients treated with intravitreal t-PA with gas injection before anti-VEGF (Group 1) or only with intravitreal anti-VEGF injection (Group 2) for SMH [disc area (DA) ≥ 2] associated with AMD from two institutions. Both groups received 3 monthly loads of anti-VEGF injections followed by injections as needed for AMD treatment. Changes in best-corrected visual acuity (BCVA, logMAR) between the initial visit and after 6 months of treatment were compared between two groups. RESULTS A total of 82 patients were enroled. Of these, 32 patients and 50 patients were grouped in Groups 1 and 2, respectively. The mean change in BCVA over 6 months for Group 1 was -0.52 ± 0.88, which was significantly larger (p = 0.044) than the mean change for Group 2 (-0.15 ± 0.58). We compared visual improvements between the two groups based on the following SMH size categories: ≤5, >5, and ≤15, and >15 DA. When the SMH size was ≤5, or >5 and ≤15 DA, the mean change in BCVA was larger for Group 1 than for Group 2, but this difference was not significant. When SMH size was >15 DA, Group 1 patients exhibited a mean visual improvement of -0.79 ± 0.80, which was significantly greater (p = 0.029) than that of Group 2 (-0.06 ± 0.67). CONCLUSIONS Patients that were primarily treated for SMH associated with AMD using t-PA and gas injection (followed by anti-VEGF injection) exhibited better visual improvement than those treated with anti-VEGF monotherapy, especially in patients exhibiting larger SMH sizes (>15 DA) at the initial visit.
References29
Newest
#2Florian BaltaH-Index: 1
Last. Timothy L Jackson ('KCL': King's College London)H-Index: 32
view all 3 authors...
Large submacular hemorrhage, an uncommon manifestation of neovascular age-related macular degeneration, may also occur with idiopathic polypoidal choroidal vasculopathy. Submacular hemorrhage damages photoreceptors owing to iron toxicity, fibrin meshwork contraction, and reduced nutrient flux, with subsequent macular scarring. Clinical and experimental studies support prompt treatment, as tissue damage can occur within 24 hours. Without treatment the natural history is poor, with a mean final vi...
42 CitationsSource
#1Joo Youn Shin (Yonsei University)H-Index: 9
#2Ji Min Lee (Yonsei University)H-Index: 2
Last. Suk Ho Byeon (Yonsei University)H-Index: 22
view all 3 authors...
Purpose To compare the treatment outcomes of a combination of pneumatic displacement and intravitreal anti–vascular endothelial growth factor, and anti–vascular endothelial growth factor monotherapy for submacular hemorrhage resulting from exudative age-related macular degeneration. Design Retrospective, comparative, interventional case series. Methods Forty eyes treated with a combination therapy and 42 eyes treated with monotherapy for submacular hemorrhage resulting from exudative age-related...
25 CitationsSource
#1Han Joo Cho (Konyang University)H-Index: 14
#2Kyoung Min KohH-Index: 1
Last. Jong Woo KimH-Index: 16
view all 8 authors...
Purpose:To evaluate the efficacy of intravitreal ranibizumab with and without pneumatic displacement for the treatment of submacular hemorrhage secondary to neovascular age-related macular degeneration.Methods:We retrospectively reviewed the medical records of 93 treatment-naive patients (93 eyes) w
14 CitationsSource
#1Jae Hui Kim (Konyang University)H-Index: 13
#2Young Suk Chang (Konyang University)H-Index: 10
Last. Han Ju Cho (Konyang University)H-Index: 1
view all 6 authors...
Purpose To evaluate the efficacy of intravitreal anti-vascular endothelial growth factor (VEGF) monotherapy for patients diagnosed with exudative age-related macular degeneration (AMD) accompanied by submacular hemorrhage. Design Retrospective, observational case series. Participants Ninety-one eyes of 91 patients who initially presented with submacular hemorrhage associated with exudative AMD from October 2009 to September 2012. Patients were followed up for at least 6 months after treatment. M...
55 CitationsSource
#1Pierluigi Iacono (UniSR: Vita-Salute San Raffaele University)H-Index: 21
#2Maurizio Battaglia Parodi (UniSR: Vita-Salute San Raffaele University)H-Index: 28
Last. Francesco Bandello (UniSR: Vita-Salute San Raffaele University)H-Index: 64
view all 6 authors...
Purpose:To evaluate the effects of intravitreal ranibizumab injections in the treatment of choroidal neovascularization with large submacular hemorrhage secondary to age-related macular degeneration.Methods:Prospective interventional case series. Patients presenting occult choroidal neovascularizati
26 CitationsSource
#1Masato Fujikawa (Shiga University of Medical Science)H-Index: 9
#2Osamu SawadaH-Index: 15
Last. Masahito OhjiH-Index: 32
view all 9 authors...
Purpose:To retrospectively evaluate efficacy, safety, and visual outcomes of pneumatic displacement for submacular hemorrhages (SMHs) with or without tissue plasminogen activator (tPA).Methods:Sixty-eight eyes with fresh SMHs underwent pneumatic displacement. Thirty eyes received intravitreal inject
22 CitationsSource
#1Han Joo Cho (Konyang University)H-Index: 14
#2Kyung Min Koh (Konyang University)H-Index: 4
Last. Jong Woo Kim (Konyang University)H-Index: 16
view all 6 authors...
Purpose To evaluate the effect of intravitreal anti–vascular endothelial growth factor (VEGF) injections on submacular hemorrhage secondary to polypoidal choroidal vasculopathy. Design Retrospective, interventional case series. Methods Twenty-seven eyes from 27 polypoidal choroidal vasculopathy patients with submacular hemorrhage involving the fovea were included in the analyses. All patients were treated by anti-VEGF injection with an initial 3 loading injections by month, followed by an as-nee...
26 CitationsSource
#1Gary Shienbaum (UM: University of Miami)H-Index: 3
#2Carlos Alexandre A. Garcia Filho (UM: University of Miami)H-Index: 12
Last. Philip J. Rosenfeld (UM: University of Miami)H-Index: 1
view all 6 authors...
Purpose To report the visual and anatomic outcomes of anti–vascular endothelial growth factor (VEGF) monotherapy in the management of marked submacular hemorrhage secondary to neovascular age-related macular degeneration (AMD). Design Retrospective, interventional, consecutive case series. Methods Nineteen eyes of 18 patients with neovascular AMD and fovea involving submacular hemorrhage comprising greater than 50% of the lesion area were treated with anti-VEGF monotherapy. Main outcome measures...
59 CitationsSource
PURPOSE: To evaluate the clinical factors associated with vitreous hemorrhage (VH) complicating intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage, and analyze visual outcomes. METHODS: In this retrospective, comparative study, 120 consecutive eyes underwent intravitreal tissue plasminogen activator (50 μg) and perfluoropropane (0.3 mL) injection for submacular hemorrhage secondary to different causes. We recorded their demographic data, visual acuity, ...
21 CitationsSource
#1Rainer Guthoff (University of Würzburg)H-Index: 12
#2Tanja GuthoffH-Index: 3
Last. Winfried GoebelH-Index: 7
view all 4 authors...
Purpose:To investigate the benefit of adding bevacizumab to intravitreal recombinant tissue plasminogen activator (rTPA) and gas as initial therapy in subretinal hemorrhage and choroidal neovascularization because of age-related macular degeneration.Methods:Thirty-eight consecutive patients with rec
37 CitationsSource
Cited By0
Newest